2021年5月5日 by 没有评论

USEUROPEAFRICAASIA中文双语FrançaisHOMECHINAWORLDBUSINESSLIFESTYLECULTURETRAVELWATCHTHISSPORTSOPINIONREGIONALFORUMNEWSPAPERChina Daily PDFChina Daily E-paperMOBILEChinaNewsSocietyInnovationHK/Taiwan/MacaoCover StoryPhotosEnvironmentHealthMilitaryHome / China / InnovationChinese scientists claim possible breakthrough in HIV, hepatitis cure
By Guo Kai | | Updated:2016-08-08 12:55A technician carries out a blood test for HIV virus at Jinan AIDS lab in East Chinas Shandong province in this file photo. [Photo/IC]Theres now hope at the end of the tunnel for patients with chronic viral infections, such as HIV and hepatitis B.
According to an article published online by Nature magazine, Chinese scientists have identified a unique subset of virus-specific CD8+ T cells playing a pivotal role in the control of viral replication during chronic infection.
Ye Lilin, a professor from the Third Military Medical University in Chongqing and a co-author of the article, said that the CD8+ T cells kill infected cells and secrete antiviral cytokines to effectively clear the virus in the acute infection.
During the chronic viral infection, the CD8+ T cells become exhausted, exhibiting poor effecter function and lose memory ability, Ye said, who is working under a national program launched in 2013. “The number of CD8+ T cells does not drop, but it seems like police stop fighting with criminals.”
However, though the exhausted cells seem to lose the function of getting rid of the virus, scientists found that they still contain viral replication in chronic infections to keep the amount of virus at a low level.
Scientists discovered that a subset of exhausted CD8+ T cells expressing the chemokine receptor CXCR5 plays a critical role in the control of viral replication in mice that were chronically infected with lymphocytic choriomeningitis virus.
Scientists called the subset as CXCR5+ CD8+ T cells that were preferentially localized in B-cell follicles, expressed lower levels of inhibitory receptors and exhibited more potent cytotoxicity.
Scientists identified the Id2/E2A axis as an important regulator for the generation of the CXCR5+ subset.
Currently, chemical drugs can only restrain the viral replication to some extent, but not clear the virus in treating patients of HIV, hepatitis B and cancers.
Ye said the new findings would allow researchers to find certain measures to improve and stabilize the function of CXCR5+ CD8+ T cells to clear the virus, offering possibility of curing these diseases.Related StoriesDating app for HIV patients a good match for those seeking loveSwindlers of people with HIV and those leaking their info must be punishedHIV/AIDS patients fall prey to identity-leak scamMicrobiome disruptions may explain HIV-exposed babies poor health: studyPhone fraudster targeted HIV patients using leaked informationJoint WHO-UNAIDS Statement on HIV information leakHIV/AIDS control in ChinaPhotoSnow storm hits XinjiangOver 1,000 police dogs serve in criminal investigation in BeijingWest Lake in riot of colors after winter rainIs it a thing? 10 odd jobs where you can make good moneyTen photos from around China: Nov 4-10Chinas new generation: Hopes, dreams and aspirationsLatestIs it a thing? 10 odd jobs where you can make good moneyMessage on a bottle: Mineral water company launches drive to find missing childrenSun Yat-sen champion of national integrity, unity: XiFour killed, two injured after house collapses in C ChinaCross-Straits forum held to commemorate Sun Yat-senState Council NewsChina seeks to replicate FTZ reform trials nationwidePremier Li visits four Eurasian countriesExclusiveIs it a thing? 10 odd jobs where you can make good moneyChinas new generation: Hopes, dreams and aspirationsHow intra-Party supervision is carried outEditors picksPlaying the waiting gameSnow leopards caught on cameraTen photos you dont wanna missTen photos from around China: Nov 4-10SpecialSixth plenum of 18th CPC Central CommitteeShenzhou XI: New frontiers, new milestoneBACK TO THE TOPHOMECHINAWORLDBUSINESSLIFESTYLECULTURETRAVELWATCHTHISSPORTSOPINIONREGIONALFORUMNEWSPAPERChina Daily PDFChina Daily E-paperMOBILECopyright 1995 -var oTime = new Date();
document.write(oTime.getFullYear());. All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.License for publishing multimedia online 0108263Registration Number: 130349About China DailyAdvertise on SiteContact UsJob OfferExpat EmploymentFOLLOW US

Leave a Comment

邮箱地址不会被公开。 必填项已用*标注

12 + 6 =